Unified Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$580K Buy
1,156
+12
+1% +$5.76K 0.53% 67
2026
Q1
$562K Buy
1,144
+75
+7% +$40.7K 0.57% 63
2025
Q4
$619K Buy
1,069
+23
+2% +$13K 0.62% 56
2025
Q3
$507K Buy
1,046
+78
+8% +$36.3K 0.51% 73
2025
Q2
$392K Buy
968
+140
+17% +$58.5K 0.42% 84
2025
Q1
$412K Buy
828
+60
+8% +$32.5K 0.49% 77
2024
Q4
$400K Buy
+768
New +$422K 0.45% 79

Other funds holding TMO

Unified Investment Management's TMO Position: Q2 2026 in Review

Unified Investment Management increased its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, buying an estimated $5.76K and bringing the position to 1,156 shares worth $580K. The position accounts for 0.53% of the portfolio, ranked #67.

Unified Investment Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $619K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Unified Investment Management held 1,156 shares of Thermo Fisher Scientific worth $580K as of Q2 2026.
  • Unified Investment Management bought 12 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.76K.
  • Thermo Fisher Scientific made up 0.53% of Unified Investment Management's portfolio in Q2 2026, its #67 holding.
  • Unified Investment Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Unified Investment Management's Thermo Fisher Scientific position peaked at $619K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Unified Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.